igf 1 lr3 protocol igf-1 dosage for muscle growth bodybuilding Peptide IGF1- LR3 Peptide IGF-1 LR3 Research: Extended Half-Life

Chronic Inflammation Systemic inflammation increases oxidative burden and glutathione utilization

The phase 3 TRIUMPH-4 data showed these rates at 9 mg and 12 mg doses respectively: Nausea: 38.1% and 43.2% (vs 10.7% placebo) Diarrhea: 34.7% and 33.1% (vs 13.4% placebo) Constipation: 21.8% and 25.0% (vs 8.7% placebo) Vomiting: 20.4% and 20.9% (vs placebo) These numbers are higher than cagrilintide monotherapy across the board

Potential Side Effects Glutathione treatments are considered safe for most people

These documented effects, among many other observations, make a strong case for the use of BPC-157 as a gut health restoring agent

E., Ogliaro F., Bearpark M., Heyd J